Skip to content

Dossier · SG · Dormant

SG · Sweetgreen, Inc.

Last analysed ·

Current thesis

May's +45% melt-up (Point72 6.2% stake ~05-15, JPM Overweight $13 on 05-22) has round-tripped: SG faded ~$9.63→$7.42 (06-05), back at consensus fair value (~$7.8 avg PT). Faded momentum, no near-term catalyst watch-only.

Invalidation trigger

Q2 comps on 2026-08-06 worse than the guided ~−4% (vs Q1's −12.8%), or a weekly close below ~$6 toward the $4.49 52-week low either kills the turnaround thesis. Conversely, a weekly close back above ~$9.50 on volume would re-arm the momentum case.

Thesis status

Open commitment scored if the trigger above fires How this is scored →

Current Thesis

The May melt-up has unwound. Sweetgreen ran +45% in May 2026 on a two-part catalyst Point72's 6.2% stake disclosure (Schedule 13G, ~2026-05-15) and JPMorgan's upgrade to Overweight, PT $8→$13 (2026-05-22, "best day in a year") then faded from ~$9.63 (May 22) to $7.42 (2026-06-05 close), roughly −23% off the pop and back at/below the consensus fair-value cluster (avg PT ~$7.8). The events that mattered are behind, and the next proof point is the 2026-08-06 Q2 print, two months out. A sentiment bounce that has already given back most of its gains, with no accelerating leg and no near-term catalyst. Watch-only.

Bull Case

  • JPMorgan Overweight, PT $8→$13 (2026-05-22) a genuine institutional sponsor flagging a free-cash-flow inflection under new management, citing strong Wraps response; the lone bull on the Street and a +11% one-day move when published.
  • Point72 / Steven Cohen 6.2% stake (Schedule 13G, 6,622,017 shares, as of 2026-05-15) smart-money accumulation disclosed mid-May; drove the +17% day on 2026-05-15 and signals hedge-fund conviction in the turnaround setup.
  • Wraps national rollout first new-product traffic lever since Ripple Fries (Q1'25), lower price point than salads; social-media reports cite a manager saying wraps approach ~half of orders, a potential comp re-accelerant if it scales system-wide.
  • Sequential comp improvement guided FY26 SSS guide of −4% to −2% with Q2 ~−4% implies a sharp narrowing from Q1's −12.8% trough as the Ripple Fries lap rolls off into H2.
  • Margin/automation optionality Infinite Kitchen automated units underpin a FY26 restaurant-level margin guide of 14.2%–14.7%; a structural cost lever if the format proves out, plus a new Chief Strategy Officer (Cindy Olsen) hire to drive transformation.

Bear Case

  • The core business is shrinking, not stabilizing: Q1 2026 revenue −2.9% YoY to $161.5M (missed $163.96M consensus), comps −12.8%, traffic −11.2% customer loss, not a weather blip.
  • Operations lose money: adjusted Q1 loss of −$0.27/sh (missed −$0.19 est.); the GAAP headline was inflated by a one-time Spyce divestiture gain, not the restaurant business. FY26 adj EBITDA guide of $1M–$6M is essentially breakeven for the whole year.
  • Price round-tripped below the May breakout: $7.42 (2026-06-05) vs the ~$9.63 post-upgrade high the momentum leg failed, and the stock sits roughly −55% below the $16.70 52-week high.
  • Street fair value is here, not higher: 13–15 analysts at Hold, average PT ~$7.8 (range $5–$13). TD Cowen maintained Hold, PT $8 (2026-05-27); JPM's $13 is the sole outlier. Upside to consensus is single digits.
  • Catalyst vacuum: the TD Cowen conference (2026-06-02) has passed, and Q2 isn't until 2026-08-06 a long dead-money window for a momentum book, with negative comps guided into the print.

Setup & Price Structure

  • $7.42 (2026-06-05 close), roughly +7% YTD after surrendering most of the May spike; high-beta name (β ~2.16), market cap ~$881M, PE ~52.
  • The May advance was a stacked sentiment event +5% (2026-05-14), +17% on the Point72 disclosure (2026-05-15), then +11% on the JPM upgrade (2026-05-22) and it has since mean-reverted ~23% off the high. The SG-specific narrative is faded/MATURING, not accelerating, even though the broader consumer-discretionary-rebound bucket still screens ACCELERATING.
  • Price now trades through the consensus target cluster (~$7.8), so reward-to-risk on a fresh long is poor without a new catalyst: upside is capped near consensus, downside opens toward the $4.49 52-week low if the turnaround stalls.
  • Chasing a stock that round-tripped its breakout and lost institutional momentum is the value-trap / faded-momentum zone the playbook avoids. A clean re-entry needs a reclaim of the May highs on volume, not bottom-fishing into a comp-negative print.

Catalyst Calendar (next 30 days)

  • No dated, market-moving catalyst within 30 days of 2026-06-07 (catalyst_date = null). The TD Cowen Future of the Consumer conference (2026-06-02) has already passed.
  • ~2026-06–07 ongoing: Wraps national-rollout adoption undated and soft; watch credit-card/foot-traffic trackers and StockTwits velocity for a comp inflection rather than a scheduled event.
  • 2026-08-06 (after close): Q2 2026 earnings the real binary. Comps vs the guided ~−4% (improvement from Q1's −12.8%) and any FY guide revision are the tells; this falls outside the 30-day window. Approaching the print with a fresh entry carries earnings-blackout binary risk.

What Would Change Our Mind

  • Bullish re-arm: a weekly close back above the ~$9.50 May-pop shelf on expanding volume reclaiming the faded breakout paired with evidence Wraps are lifting traffic (credit-card data, management commentary). That flips this from value trap to confirmed turnaround and warrants a re-look.
  • Comp confirmation: Q2 (2026-08-06) comps materially better than the guided ~−4% with positive traffic would validate the inflection thesis and justify chasing above $11–12.
  • Bearish confirmation: a daily/weekly close below ~$6 toward the $4.49 52-week low confirms the value trap and ends any turnaround case; likewise Q2 comps worse than Q1's −12.8% would invalidate the recovery narrative entirely.

Correlation Notes

  • Trades with fast-casual / restaurant peers (CAVA, CMG, WING) and the consumer-discretionary-rebound + rate-relief-cyclicals themes; high beta (~2.16) amplifies broad-market and consumer-spending swings (jobs reports, retail-sales prints, rate expectations).
  • Idiosyncratic crowding risk from the hedge-fund footprint (Point72 6.2%) cuts both ways a 13F/13G unwind would pressure the stock independent of fundamentals, just as the disclosure drove the May squeeze.
  • The Wraps value-pricing angle ties SG to the broader QSR value-war narrative (lower-ticket menu pushes across the group); peer comp commentary into Q2 earnings season is a read-through tell ahead of the 2026-08-06 print.

Bottom Line

Faded momentum sitting on a still-unproven turnaround. The pop has unwound, the catalysts are spent, and the next dated proof point is two months out no accelerating leg to buy at $7.42.

Notes

  • Q2 2026 earnings: 2026-08-06 after close the real binary; comps vs Q1's −12.8% is the tell. Blackout avoid if approaching with a fresh entry.
  • EPS 'beats' are noise here Q1 $1.05 was a one-time Spyce divestiture gain, not operations. Track adj EBITDA (FY guide $1–6M) and comps, NOT headline EPS.
  • Street target cluster $4.50–$9.00 (avg $6.74); JPM $13 is the lone bull. Stock already trades above consensus fair value poor R:R for fresh longs.
  • Value-trap watch: cheap + a bounce ≠ accelerating narrative. Only chase on a >$11–12 breakout WITH comps confirmation; otherwise this is dead money until Aug 6.
  • Theme engine tags this ACCELERATING via the cyclical-rebound bucket, but the SG-specific narrative is MATURING/faded post the 2026-05-22 upgrade pop.
  • Q2 2026 earnings: 2026-08-06 after close the real binary. Comps vs the guided ~−4% (improvement from Q1's −12.8%) is the tell. Earnings-blackout risk if approaching with a fresh entry.
  • May +45% pop has round-tripped: faded from ~$9.63 (05-22) to $7.42 (06-05), below the $8 level the prior dossier flagged. Momentum leg failed confirms the faded-momentum/value-trap read.
  • May spike was a stacked sentiment event: +5% (05-14), +17% on Point72's 6.2% 13G disclosure (05-15), +11% on JPM Overweight $13 (05-22). Hedge-fund crowding cuts both ways 13F/13G unwind risk.
  • EPS headlines are noise: Q1 GAAP was inflated by a one-time Spyce divestiture gain; operations posted an adjusted −$0.27/sh loss. Track adj EBITDA (FY guide $1–6M) and comps, NOT headline EPS.
  • Street: 13–15 analysts Hold, avg PT ~$7.8 (range $5–$13). TD Cowen Hold, PT $8 (05-27). JPM $13 is the lone bull. Price now trades through consensus single-digit upside to fair value.
  • Value-trap watch: only chase on a >$11–12 breakout WITH Q2 comp confirmation, or a reclaim of the ~$9.50 May shelf on volume. Otherwise dead money until 08-06.
  • 52-week range updated to $4.49–$16.70 (was $16.26 high). Current $7.42 ≈ −55% off the high, +65% off the low; high beta ~2.16.

Related · shared themes